Target Gene/Pathway（薬物標的遺伝子／パスウェイリスト）💬 Info on mouse-over

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	指定難病告示番号
1	Coronavirus disease - COVID-19 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
2	Cytokine-cytokine receptor interaction 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
3	EGFR tyrosine kinase inhibitor resistance 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
4	Hematopoietic cell lineage 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
5	HIF-1 signaling pathway 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
6	Human cytomegalovirus infection 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
7	JAK-STAT signaling pathway 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
8	Non-alcoholic fatty liver disease 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
9	Pathways in cancer 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
10	PI3K-Akt signaling pathway 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
11	Th17 cell differentiation 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
12	Viral protein interaction with cytokine and cytokine receptor 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬

先頭へ